Prostate cancer management – Selecting the right treatment for the right patient

Industry session by FERRING

  • Location:
    Room London (Hall B2, level 0)
  • Chair:
     F. Montorsi, Milan (IT)
  • Aims and objectives of this session

    • Review current best practice in prostate cancer management through presentation and discussion of case reports from patients with prostate cancer, highlighting the heterogeneity in comorbidities, side effects experienced, and treatment options available
    • To discuss the risk/benefit ratio of treatments based on the clinical characteristics and risk factors of patients from an individual perspective
    • To discuss how patients can manage their prostate cancer and the side effects of treatment through lifestyle changes, enabling patients to take control of their disease and treatment

Welcome and introduction: An overview of the current prostate cancer treatment landscape
 F. Montorsi, Milan (IT)
How best to manage patients with advanced prostate cancer presenting with high burden metastatic disease
 J.P.M. Sedelaar, Nijmegen (NL)
Determining the right patients for neoadjuvant/adjuvant therapy
 H. Payne, London (GB)
What is the prevalence of CVD in patients with prostate cancer and how do we assess CV risk when deciding treatment strategy?
 A. Lyon, London (GB)
Managing treatment side effects through lifestyle changes: Empowering patients to take control
 F. Montorsi, Milan (IT)
Discussion summary and concluding remarks
 F. Montorsi, Milan (IT)